Generalized Anxiety Disorder

• FDA label_change · 2025-12-29
  FDA Approved: PREGABALIN — Supplemental Application (Cipla USA, Inc.)

  FDA approved a supplemental application for Pregabalin submitted by Cipla USA, Inc., indicating changes to the drug's labeling. The notice d…

• FDA label_change · 2024-06-12
  FDA Approved: PAROXETINE — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for PAROXETINE HYDROCHLORIDE submitted by Zydus Lifesciences Limited, resulting in changes to the pr…

• FDA label_change · 2023-08-18
  FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)

  The FDA approved a supplemental application for venlafaxine from Alembic Pharmaceuticals, resulting in labeling updates for the generic prod…

• FDA label_change · 2021-09-20
  FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)

  FDA notice of a supplemental labeling application for VENLAFAXINE by Alembic Pharmaceuticals Inc.

• FDA label_change · 2021-09-15
  FDA Approved: ALPRAZOLAM — Supplemental Application (Sandoz Inc)

  FDA approved a supplemental application for Alprazolam submitted by Sandoz Inc, resulting in changes to the product labeling.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA label_change · 2018-08-13
  FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)

  FDA approved a supplemental application for venlafaxine hydrochloride filed by Macleods Pharmaceuticals Limited. The approval is associated …

• FDA label_change · 2017-01-04
  FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)

  FDA approved a supplemental labeling change for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC. The supplemental …

• FDA label_change · 2015-10-19
  FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Exelan Pharmaceuticals Inc.)

  FDA approved a supplemental application for Escitalopram Oxalate by Exelan Pharmaceuticals, indicating a change to the drug's labeling under…

• FDA label_change · 2014-07-18
  FDA Approved: VENLAFAXINE — Supplemental Application (BluePoint Laboratories)

  FDA approved a supplemental application for Venlafaxine from BluePoint Laboratories. The update concerns this generic product's regulatory s…

• FDA label_change · 2011-08-22
  FDA Approved: ALPRAZOLAM — Supplemental Application (Aurobindo Pharma Limited)

  FDA approves a supplemental application for alprazolam submitted by Aurobindo Pharma Limited.

• FDA label_change · 2008-02-07
  FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)

  The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.

• FDA label_change · 2008-01-30
  FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)

  The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) from Viatris Specialty LLC, updating the product labe…